TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says August 29, 2008
TCL Archive NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case October 7, 1977
TCL Archive CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research April 8, 2011
TCL Archive ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application September 24, 1999
